New Notre Dame research has been used to support the Orphan Drug designation for IT-139, a compound that when used in combination with chemotherapy has proved to be significantly more effective in treating pancreatic cancer than the current standard of care.
The Harper Cancer Research Institute is changing the way we fight cancer.
Located in South Bend, Indiana, HCRI researchers are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. From common malignancies to rare and recalcitrant cancers, researchers at the University of Notre Dame and Indiana University School of Medicine - South Bend are united in multi-disciplinary teams with a common goal: to increase the survival of all patients diagnosed with cancer.
A collaboration between the University of Notre Dame and the Indiana University School of Medicine South Bend
University of Notre Dame and Indiana University School of Medicine, South Bend